# BD Agrees to Combine Biosciences and Diagnostic Solutions Business With Waters Corporation in $17.5 Billion Reverse Morris Trust

> ma · REPORTED · 2025-07-01

BD announced in July 2025 a definitive agreement to combine its Biosciences and Diagnostic Solutions business with Waters Corporation in a tax-efficient Reverse Morris Trust transaction valued at approximately $17.5 billion. The deal pairs Waters' chromatography and mass spectrometry expertise with BD's biologics and diagnostics capabilities.

- Company: BD / Waters Corporation
- Sector: diagnostics
- Primary source: https://www.massdevice.com/medtech-biggest-deals-of-2025/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.